Zoe Kemp

5.0k total citations
27 papers, 580 citations indexed

About

Zoe Kemp is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Zoe Kemp has authored 27 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 11 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Zoe Kemp's work include BRCA gene mutations in cancer (10 papers), Genetic factors in colorectal cancer (8 papers) and Cancer Genomics and Diagnostics (5 papers). Zoe Kemp is often cited by papers focused on BRCA gene mutations in cancer (10 papers), Genetic factors in colorectal cancer (8 papers) and Cancer Genomics and Diagnostics (5 papers). Zoe Kemp collaborates with scholars based in United Kingdom, United States and Spain. Zoe Kemp's co-authors include Angela George, Nazneen Rahman, Shazia Mahamdallie, Ann Strydom, Sheila Seal, Andrew Rowan, Martin Gore, Helen Hanson, Susana Banerjee and Sabrina Talukdar and has published in prestigious journals such as JAMA, Cancer Research and Scientific Reports.

In The Last Decade

Zoe Kemp

23 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zoe Kemp United Kingdom	12	316	258	225	179	148	27	580
Jacqueline Mersch United States	3	333 1.1×	173 0.7×	185 0.8×	123 0.7×	148 1.0×	9	544
Rachel T. Klein United States	10	354 1.1×	140 0.5×	204 0.9×	299 1.7×	205 1.4×	15	600
Gemma Llort Spain	14	435 1.4×	149 0.6×	314 1.4×	144 0.8×	161 1.1×	32	638
Agnès Hardouin France	13	333 1.1×	218 0.8×	392 1.7×	117 0.7×	136 0.9×	25	778
Eli Marie Grindedal Norway	10	196 0.6×	161 0.6×	102 0.5×	208 1.2×	138 0.9×	17	405
Jacquelyn Powers United States	11	324 1.0×	139 0.5×	108 0.5×	110 0.6×	156 1.1×	27	458
Ryan Bernhisel United States	12	260 0.8×	162 0.6×	142 0.6×	137 0.8×	184 1.2×	23	462
Kerstin Rhiem Germany	15	572 1.8×	184 0.7×	258 1.1×	175 1.0×	312 2.1×	28	786
H Ozçelik Canada	9	414 1.3×	168 0.7×	242 1.1×	112 0.6×	160 1.1×	15	644
Brigette Tippin Davis United States	9	373 1.2×	114 0.4×	184 0.8×	88 0.5×	126 0.9×	12	543

Countries citing papers authored by Zoe Kemp

Since Specialization

Citations

This map shows the geographic impact of Zoe Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoe Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoe Kemp more than expected).

Fields of papers citing papers by Zoe Kemp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoe Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoe Kemp. The network helps show where Zoe Kemp may publish in the future.

Co-authorship network of co-authors of Zoe Kemp

This figure shows the co-authorship network connecting the top 25 collaborators of Zoe Kemp. A scholar is included among the top collaborators of Zoe Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoe Kemp. Zoe Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Clarke, Caroline S., Christopher M. Bunce, Richard Lee, et al.. (2025). Li Fraumeni syndrome in the UK: clinical characteristics and outcomes of TP53 carriers. ESMO Open. 10(9). 105541–105541.

Christopher, Joseph, et al.. (2025). Recontact and follow-up for individuals with germline pathogenic variants in hereditary breast and ovarian cancer susceptibility genes: a UK Cancer Genetics Group consensus meeting. Journal of Medical Genetics. 63(1). 57–63.

Walker, Orville C., Marcos Arango, Barnaby Thwaites, et al.. (2024). 194P Monitoring for pneumonitis due to trastuzumab deruxtecan (T-DXd): A single centre experience. ESMO Open. 9. 103216–103216.

Gelmon, Karen A., PA Fasching, Suzette Delaloge, et al.. (2023). 203P Clinical effectiveness of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer (mBC) by ER expression level: Subgroup analysis from phase IIIb LUCY trial. ESMO Open. 8(1). 101392–101392. 1 indexed citations

Abraham, Jean, Katie Snape, Katrina Tatton‐Brown, et al.. (2023). Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologists. Clinical Medicine. 23(1). 9–15. 11 indexed citations

Monje‐Garcia, Laura, Emma Kipps, Angela F. Brady, et al.. (2023). From diagnosis of colorectal cancer to diagnosis of Lynch syndrome: The RM Partners quality improvement project. Colorectal Disease. 25(9). 1844–1851. 4 indexed citations

Torr, Bethany, Stephen MacMahon, Angela George, et al.. (2023). LBA101 BRCA-DIRECT: A randomised UK study evaluating a digital pathway for germline genetic testing and non-inferiority of digitally-delivered information in women with breast cancer. Annals of Oncology. 34. S1339–S1339. 1 indexed citations

Openshaw, Mark R., et al.. (2022). Mismatch Repair Screening of Gastrointestinal Cancers: The Impact on Lynch Syndrome Detection and Immunotherapy. Journal of Gastrointestinal Cancer. 54(3). 768–775. 1 indexed citations

Richardson, Caroline R., et al.. (2022). Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?. The Breast. 67. 30–35. 14 indexed citations

10.

Jatoi, Ismail & Zoe Kemp. (2021). Risk-Reducing Mastectomy. JAMA. 325(17). 1781–1781. 12 indexed citations

11.

Kemp, Zoe, Shawn Yost, Sheila Seal, et al.. (2019). Evaluation of Cancer-Based Criteria for Use in MainstreamBRCA1andBRCA2Genetic Testing in Patients With Breast Cancer. JAMA Network Open. 2(5). e194428–e194428. 78 indexed citations

12.

McVeigh, Terri, et al.. (2017). Successful Repatriation of Breast Cancer Surveillance for High-Risk Women to the UK National Health Service Breast Screening Programme. Clinical Breast Cancer. 18(4). 282–288. 1 indexed citations

13.

George, Angela, Sheila Seal, Sabrina Talukdar, et al.. (2016). Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients. Scientific Reports. 6(1). 29506–29506. 157 indexed citations

14.

Kemp, Zoe. (2013). Applying an ecosystems approach to land use - Stirling ecosystems approach demonstration project: Developing a methodology. 1 indexed citations

15.

Kemp, Zoe & Alison Jones. (2011). A shift in the treatment of hormone receptor and human epidermal growth factor receptor 2-positive metastatic breast cancer. Advances in Therapy. 28(8). 603–614. 5 indexed citations

16.

Kemp, Zoe. (2006). Evidence for a colorectal cancer susceptibility locus on chromosome 3q21-q24 from a high-density SNP genome-wide linkage scan. Human Molecular Genetics. 15(19). 2903–2910. 38 indexed citations

17.

Kemp, Zoe, Luis G. Carvajal‐Carmona, Ella Barclay, et al.. (2006). Evidence of Linkage to Chromosome 9q22.33 in Colorectal Cancer Kindreds from the United Kingdom. Cancer Research. 66(10). 5003–5006. 38 indexed citations

18.

Rowan, Andrew, Sarah Halford, Michelle Gaasenbeek, et al.. (2005). Refining Molecular Analysis in the Pathways of Colorectal Carcinogenesis. Clinical Gastroenterology and Hepatology. 3(11). 1115–1123. 43 indexed citations

19.

Kemp, Zoe, Andrew Rowan, William Chambers, et al.. (2005). CDC4 Mutations Occur in a Subset of Colorectal Cancers but Are Not Predicted to Cause Loss of Function and Are Not Associated with Chromosomal Instability. Cancer Research. 65(24). 11361–11366. 70 indexed citations

20.

Kemp, Zoe. (2004). An update on the genetics of colorectal cancer. Human Molecular Genetics. 13(suppl_2). R177–R185. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact